Lactobacillus paracasei Vesicles for Metabolic Disorder Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for obesity and insulin resistance do not effectively address metabolic disorders caused by high-fat diets, particularly in animal models, and there is a lack of therapeutic use of Lactobacillus-derived vesicles for these conditions.
Innovation Solution
A pharmaceutical and food composition utilizing isolated vesicles from Lactobacillus paracasei bacteria, which are administered to inhibit obesity and insulin resistance by reducing body weight, food intake, and improving metabolic disorders through AMPK signaling activation in myocytes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Lactobacillus-derived vesicles are used to treat obesity and insulin resistance, then metabolic disorders are improved, but the therapeutic mechanism and effectiveness in animal models need further validation
Solution Approach 1:
The patent converts the harmful effect of high-fat diet-induced metabolic disorders into a beneficial therapeutic opportunity by using Lactobacillus vesicles to treat obesity and insulin resistance. The vesicles are derived from bacterial components that normally could be considered harmful (bacterial cell wall components like peptidoglycan and lipoteichoic acid) but are repurposed to activate AMPK signaling and improve metabolic health.
2Weight of moving object
If isolated vesicles from Lactobacillus paracasei are administered, then body weight and food intake are reduced, but the mechanism of action requires further elucidation
Solution Approach 1:
The patent employs feedback mechanisms by measuring various parameters (body weight, food intake, metabolic markers) to evaluate the therapeutic effect of Lactobacillus vesicles. The AMPK signaling pathway activation serves as a molecular feedback indicator that confirms the mechanism of action, allowing researchers to correlate vesicle administration with specific biochemical changes.
3Adaptability or versatility
If vesicles are secreted by Lactobacillus bacteria, then intracellular exchange of proteins, lipids or genes is enabled, but the therapeutic application for metabolic diseases is not yet established
Solution Approach 1:
The patent demonstrates universality by showing that Lactobacillus vesicles, which naturally function in intracellular exchange of proteins, lipids, and genes, can also serve multiple therapeutic functions in treating metabolic diseases. The same vesicles that enable bacterial communication are shown to activate AMPK signaling, reduce body weight, and improve insulin sensitivity across different metabolic disorder models.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The vesicles derived from Lactobacillus paracasei effectively reduce body weight and metabolic disorders by activating AMPK signaling, demonstrating potential in treating obesity, metabolic syndrome, and related conditions in animal models.
Implementation Method 1
improving metabolic disorders through AMPK signaling activation in myocytes
Data Source
Figure 1
Figure 2A~2C
Figure 3
AI summary
The present invention relates to a composition for preventing or treating a metabolic disease or muscle disease, which comprises vesicles derived from bacteria of the genus Lactobacillus. The inventors confirmed that, when vesicles derived from bacteria of the genus Lactobacillus were administered into an animal model with a metabolic disease caused by a high fat, the vesicles effectively inhibit metabolic diseases caused by a high fat diet, and increase homeostasis to metabolic stress by activating AMPK signaling in myocytes, and therefore, the vesicles derived from bacteria of the genus Lactobacillus according to the present invention can be effectively used in development of pharmaceuticals or health functional foods for preventing, improving symptoms or treating metabolic diseases such as obesity and muscle diseases.